
Episode #35
[USA] Regulatory Updates on Federal Detainee, FOP, Ammunition & Fraud
This episode covers vital regulatory and enforcement developments across public health and criminal justice sectors, including Federal Detainee convictions, FDA drug approvals, and fraud investigations. Noteworthy updates include the FDA's warning about Vital Honey products containing undeclared tadalafil, posing health risks and prompting consumer advisories. Additionally, the FDA approved Atebrioz tablets as the third treatment option for Fibrodysplasia Ossificans Progressiva, offering new hope for patients. In criminal enforcement, multiple convictions were secured: a federal detainee was convicted for assaulting correctional officers, and significant sentences were handed down for unlawful ammunition possession and illegal reentry cases as part of Operation Take Back America. Furthermore, a man in California pled guilty to a COVID-19 PPP loan fraud scheme, emphasizing the ongoing crackdown on pandemic-related financial crimes. For more information, visit the Carver Agents website . Articles mentioned: Inland Empire Man Pleads Guilty to His Role in Crime Ring that Fraudulently Obtained $3.5 Million in COVID Business-Relief Loans Public Notification: Vital Honey contains hidden drug ingredient Capitvo Inc. Federal Detainee Convicted of Assaulting Kankakee County Correctional Officers Former U.S. Soldier Sentenced for Hacking and Extortion Scheme That Exposed Sensitive Data of U.S. Government Official FDA Approves Third Treatment for Fibrodysplasia Ossificans Progressiva Criminal Illegal Alien from Mexico Convicted of Unlawful Possession of Ammunition Previously deported alien residing in Sacramento sentenced to 31 months in prison for illegally possessing firearms and illegal reentry New Filings - Week of September 14-18, 2026 Attorney General James’ Office of Special Investigation Releases Report on the Death of Shelton Ennis

